Reducing Reliance on Nexium, Prilosec, Similar Drugs Not Only Saves Money, But Study Indicates It Will Do No Harm
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Nexium, Dexilant Lawsuit Filed Over Chronic Kidney Disease Diagnosis December 27, 2017 Irvin Jackson Add Your Comments A recently filed product liability lawsuit alleges that the combined side effects of Nexium and Dexilant caused a North Carolina woman to develop a case of chronic kidney disease, following long-term use of the popular heartburn drugs. Sharon Blythe filed the complaint (PDF) in the U.S. District Court for the District of New Jersey on December 21, indicating that the drug makers AstraZeneca and Takeda Pharmaceuticals failed to adequately warn consumers and the medical community about the potential kidney risks. According to the lawsuit, Blythe was prescribed Nexium and Dexilant repeatedly from 2006 through 2014, and the 61 year old was subsequently diagnosed with chronic kidney disease, which was alleges caused by exposure to the medications that are both part of a class of drugs known as proton pump inhibitors (PPIs) that have been linked to similar reports. Learn More About Nexium, Prilosec and Other Acid Reflux Drug Lawsuits Nexium, Prilosec and other acid reflux drug side effects may increase risk of kidney injury. Lawsuits reviewed. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Nexium, Prilosec and Other Acid Reflux Drug Lawsuits Nexium, Prilosec and other acid reflux drug side effects may increase risk of kidney injury. Lawsuits reviewed. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Blythe maintains that neither she nor the medical community were provided with adequate information about the risk of chronic kidney disease and other kidney problems associated with Nexium, Dexilant, and other PPIs, which also include popular medications like Prilosec and Prevacid. If she had been warned, Blythe indicates that she would have taken another type of heartburn medication, which does not carry the same risks. In recent years, several studies have highlighted serious concerns about the kidney risks with Nexium and other PPI medications, raising questions about why AstraZeneca and other drug makers withheld important safety warnings. In an independent study published by the medical journal CMAJ Open in April 2015, researchers found that users of PPI medications were three times more likely to suffer acute interstitial nephritis, which involves inflammation of the kidney. In addition, the study found that users were 2.5 times more likely to develop acute kidney injury (AKI), which involves an abrupt loss of kidney function. This research was followed by a study published last year in the medical journal JAMA Internal Medicine, which also found an increased risk of chronic kidney disease (CKD) with the heartburn medications, indicating that users of Nexium, Prilosec and other PPI may be 50% more likely when compared to non-users. In April 2016, researchers with the Department of Veterans Affairs found that users of Nexium, Prilosec or other PPIs may be 96% more likely to develop renal failure and 28% more likely to develop chronic kidney disease after five years of use. “Defendants negligently represented to the medical and healthcare community, the FDA, to Plaintiff and the public that Nexium and Dexilant had been tested and were found to be safe and/or effective for their indicated use,” Blythe’s lawsuit states. “Defendants, at all relevant times, knew or should have known of the risks and defects with Nexium and Dexilant products, however Defendants concealed their knowledge of Nexium’s and Dexilant’s risks and defects and failed to notify Plaintiff, the FDA, the public and the medical community including Plaintiff’s prescribing physicians of the risks of CKD and AKI.” Blythe’s case joins a growing number of other Nexium lawsuits, Dexilant lawsuits, Prilosec lawsuits, Protonix lawsuits, and Prevacid lawsuits brought by individuals nationwide in recent months, each raising similar allegations that the drug makers withheld information about the risks associated with long-term use of the medications. Given common questions of fact and law raised in the cases brought throughout the federal court system, the U.S. Judicial Panel on Multidistrict Litigation (JPML) issued an order earlier this month, consolidating all heartburn kidney lawsuits before one judge in New Jersey federal court for pretrial proceedings. As heartburn drug injury lawyers continue to review and file cases in the coming months and years, it is expected that hundreds, if not thousands, of similar acute interstitial nephritis lawsuits may be filed over the failure to warn about the side effects of Nexium, Dexilant, and other PPI medications. Tags: AstraZeneca, Chronic Kidney Disease, Dexilant, Heartburn, Heartburn Drugs, Nexium, Proton Pump Inhibitors, Takeda Pharmaceuticals More Proton Pump Inhibitor Lawsuit Stories Reducing Reliance on Nexium, Prilosec, Similar Drugs Not Only Saves Money, But Study Indicates It Will Do No Harm April 15, 2024 Nexium, Prilosec Settlement Reached To Resolve Kidney Damage Lawsuits Against AstraZeneca October 4, 2023 Heartburn Drugs Like Nexium, Prilosec May Increase Risk of Serious Childhood Infections: Study August 17, 2023 1 Comments Tina May 1, 2021 I took Dexilant for over a year. I know have stage 3 renal failure. Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: yesterday) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025) Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: 2 days ago) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025) BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (Posted: 3 days ago) A Massachusetts woman’s injuries from a failed tissue marker that was recently recalled led to the need for physical therapy, according to a BioZorb implant lawsuit. MORE ABOUT: BIOZORB LAWSUITFour Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025)Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (04/02/2025)
Reducing Reliance on Nexium, Prilosec, Similar Drugs Not Only Saves Money, But Study Indicates It Will Do No Harm April 15, 2024
Nexium, Prilosec Settlement Reached To Resolve Kidney Damage Lawsuits Against AstraZeneca October 4, 2023
Heartburn Drugs Like Nexium, Prilosec May Increase Risk of Serious Childhood Infections: Study August 17, 2023
MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: yesterday) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025)
Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: 2 days ago) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025)
BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (Posted: 3 days ago) A Massachusetts woman’s injuries from a failed tissue marker that was recently recalled led to the need for physical therapy, according to a BioZorb implant lawsuit. MORE ABOUT: BIOZORB LAWSUITFour Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025)Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (04/02/2025)